{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:37:21Z","timestamp":1770158241852,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/04462: iNOVA4Health"],"award-info":[{"award-number":["UID\/04462: iNOVA4Health"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/W1224"],"award-info":[{"award-number":["10.55776\/W1224"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34826-2","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T04:56:18Z","timestamp":1767934578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Streamlined rAAV HeLaS3 producer cell line generation via GS selection"],"prefix":"10.1038","volume":"16","author":[{"given":"Mariana","family":"Antunes","sequence":"first","affiliation":[]},{"given":"Filipa","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Ivy Rose","family":"Sebastian","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Gomes-Alves","sequence":"additional","affiliation":[]},{"given":"Jose M.","family":"Escandell","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"2","key":"34826_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/v17020239","volume":"17","author":"L Zwi-Dantsis","year":"2025","unstructured":"Zwi-Dantsis, L., Mohamed, S., Massaro, G. & Moeendarbary, E. Adeno-associated virus vectors: principles, practices, and prospects in gene therapy. Viruses 17(2), 239; https:\/\/doi.org\/10.3390\/v17020239 (2025).","journal-title":"Viruses"},{"key":"34826_CR2","doi-asserted-by":"publisher","first-page":"112265","DOI":"10.1016\/j.isci.2025.112265","volume":"28","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. The clinical safety landscape for ocular AAV gene therapies: a systematic review and meta-analysis. iScience 28, 112265; https:\/\/doi.org\/10.1016\/j.isci.2025.112265 (2025).","journal-title":"iScience"},{"key":"34826_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18609\/CGTI.2024.095","volume":"10","author":"CA Reid","year":"2024","unstructured":"Reid, C. A., H\u00f6rer, M. & Mandegar, M. A. Advancing AAV production with high-throughput screening and transcriptomics. Cell Gene. Ther. Insights 10, 821\u2013840;\u00a0\u00a0https:\/\/doi.org\/10.18609\/CGTI.2024.095 (2024).","journal-title":"Cell Gene. Ther. Insights"},{"key":"34826_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/microorganisms12020384","volume":"12","author":"O-W Merten","year":"2024","unstructured":"Merten, O.-W. Development of stable packaging and producer cell lines for the production of AAV vectors. Microorganisms 12, 384; https:\/\/doi.org\/10.3390\/microorganisms12020384 (2024).","journal-title":"Microorganisms"},{"key":"34826_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.copbio.2021.12.009","volume":"74","author":"JM Escandell","year":"2022","unstructured":"Escandell, J. M. et al. Leveraging rAAV bioprocess understanding and next generation bioanalytics development. Curr. Opin. Biotechnol. 74, 271\u2013277;  https:\/\/doi.org\/10.1016\/j.copbio.2021.12.009 (2022).","journal-title":"Curr. Opin. Biotechnol."},{"key":"34826_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/hum.1995.6.10-1329","volume":"6","author":"KR Clark","year":"1995","unstructured":"Clark, K. R., Voulgaropoulou, F., Fraley, D. M. & Johnson, P. R. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene. Ther. 6, 1329\u20131341; https:\/\/doi.org\/10.1089\/hum.1995.6.10-1329 (1995).","journal-title":"Hum. Gene. Ther."},{"key":"34826_CR7","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/bit.28394","volume":"120","author":"J Escandell","year":"2023","unstructured":"Escandell, J. et al. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line. Biotechnol. Bioeng. 120, 2578\u20132587; https:\/\/doi.org\/10.1002\/bit.28394 (2023).","journal-title":"Biotechnol. Bioeng."},{"key":"34826_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/hgtb.2013.046","volume":"24","author":"J Martin","year":"2013","unstructured":"Martin, J. et al. Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production. Hum. Gene. Ther. Methods 24, 253\u2013269; https:\/\/doi.org\/10.1089\/hgtb.2013.046 (2013).","journal-title":"Hum. Gene. Ther. Methods"},{"key":"34826_CR9","doi-asserted-by":"publisher","unstructured":"Escandell, J. M. et al. Development of a serum-free producer cell line generation process for scalable and efficient rAAV production for gene therapy applications. bioRxiv. https:\/\/doi.org\/10.1101\/2025.10.02.679972 (2025).","DOI":"10.1101\/2025.10.02.679972"},{"key":"34826_CR10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/bit.26552","volume":"115","author":"DY Yu","year":"2018","unstructured":"Yu, D. Y., Lee, S. Y. & Lee, G. M. Glutamine synthetase gene knockout-human embryonic kidney 293E cells for stable production of monoclonal antibodies. Biotechnol. Bioeng. 115, 1367\u20131372; https:\/\/doi.org\/10.1002\/bit.26552 (2018).","journal-title":"Biotechnol. Bioeng."},{"key":"34826_CR11","doi-asserted-by":"publisher","first-page":"16768","DOI":"10.1038\/s41598-019-53391-z","volume":"9","author":"CL Chin","year":"2019","unstructured":"Chin, C. L. et al. A human expression system based on HEK293 for the stable production of recombinant erythropoietin. Sci. Rep. 9, 16768; https:\/\/doi.org\/10.1038\/s41598-019-53391-z (2019).","journal-title":"Sci. Rep."},{"key":"34826_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4155\/PBP.13.56","volume":"1","author":"L Fan","year":"2013","unstructured":"Fan, L., Frye, C. C. & Racher, A. J. The use of glutamine synthetase as a selection marker: recent advances in Chinese hamster ovary cell line generation processes. Pharm. Bioprocess 1, 487\u2013502; https:\/\/doi.org\/10.4155\/PBP.13.56 (2013).","journal-title":"Pharm. Bioprocess"},{"key":"34826_CR13","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","volume":"110","author":"A Srivastava","year":"2021","unstructured":"Srivastava, A., Mallela, K. M. G., Deorkar, N. & Brophy, G. Manufacturing challenges and rational formulation development for AAV viral vectors. J. Pharm. Sci. 110, 2609\u20132624; https:\/\/doi.org\/10.1016\/j.xphs.2021.03.024 (2021).","journal-title":"J. Pharm. Sci."},{"key":"34826_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101266","volume":"32","author":"W Xue","year":"2024","unstructured":"Xue, W. et al. Adeno-associated virus perfusion enhanced expression: a commercially scalable, high titer, high quality producer cell line process. Mol. Ther. Methods Clin. Dev. 32, 101266; https:\/\/doi.org\/10.1016\/j.omtm.2024.101266 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"34826_CR15","doi-asserted-by":"publisher","first-page":"10399","DOI":"10.1039\/D2NR02150A","volume":"14","author":"A Prasad","year":"2022","unstructured":"Prasad, A. et al. Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0\/G1 cell cycle arrest. Nanoscale 14, 10399\u201310417;\u00a0https:\/\/doi.org\/10.1039\/D2NR02150A (2022).","journal-title":"Nanoscale"},{"key":"34826_CR16","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/S0021-9258(17)30124-2","volume":"254","author":"LJ Reitzer","year":"1979","unstructured":"Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669\u201376 (1979).","journal-title":"J. Biol. Chem."},{"key":"34826_CR17","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.1038\/s41598-023-37288-6","volume":"13","author":"W Srila","year":"2023","unstructured":"Srila, W. et al. Glutamine synthetase (GS) knockout (KO) using CRISPR\/Cpf1 diversely enhances selection efficiency of CHO cells expressing therapeutic antibodies. Sci. Rep. 13, 10473; https:\/\/doi.org\/10.1038\/s41598-023-37288-6 (2023).","journal-title":"Sci. Rep."},{"key":"34826_CR18","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1002\/bit.28412","volume":"120","author":"Q Fu","year":"2023","unstructured":"Fu, Q., Polanco, A., Lee, Y. S. & Yoon, S. Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing. Biotechnol. Bioeng. 120, 2601\u20132621; https:\/\/doi.org\/10.1002\/bit.28412 (2023).","journal-title":"Biotechnol. Bioeng."},{"key":"34826_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2024.108433","author":"F Destro","year":"2024","unstructured":"Destro, F. et al. The state of technological advancement to address challenges in the manufacture of rAAV gene therapies. Biotechnol. Adv. https:\/\/doi.org\/10.1016\/j.biotechadv.2024.108433 (2024).","journal-title":"Biotechnol. Adv."},{"key":"34826_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28932","author":"JK Lorek","year":"2025","unstructured":"Lorek, J. K., Isaksson, M. & Nilsson, B. Chromatography in downstream processing of recombinant adeno-associated viruses: a review of current and future practises. Biotechnol. Bioeng. https:\/\/doi.org\/10.1002\/bit.28932 (2025).","journal-title":"Biotechnol. Bioeng."},{"key":"34826_CR21","unstructured":"FDA. Manufacturing changes and comparability for human cellular and gene therapy products; draft guidance for industry. http:\/\/www.regulations.gov. (2023)."},{"key":"34826_CR22","doi-asserted-by":"publisher","unstructured":"Fernandes, S., Guerra, J., Ferreira, M. V. & Coroadinha, A. S. Deciphering key adenoviral elements in the production of recombinant adeno-associated virus vectors. Hum Gene Ther 36; https:\/\/doi.org\/10.1089\/hum.2024.265 (2025).","DOI":"10.1089\/hum.2024.265"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34826-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:28:47Z","timestamp":1770110927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34826-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34826-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4658"}}